Martin Brenner - Nov 1, 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Signature
/s/ Martin Brenner
Stock symbol
IBIO
Transactions as of
Nov 1, 2023
Transactions value $
-$1,296
Form type
4
Date filed
11/3/2023, 04:01 PM
Previous filing
Oct 5, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Sale -$1.3K -4.88K -2.6% $0.27 183K Nov 1, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2654 to $0.2671 inclusive. The Reporting Person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon report, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

Chief Executive Officer and Chief Scientific Officer